Neuro-Oncology Reviews
Volume
26 Number 23
20 October 2024
Home > Publications > Neuro-Oncology Reviews > Volume 26, Year 2024 > Number 23, 20 October
Angelico G, Mazzucchelli M, Attanasio G, Tinnirello G, Farina J,
Zanelli M, Palicelli A, Bisagni A, Barbagallo GMV, Certo F, Zizzo
M, Koufopoulos N, Magro G, Caltabiano R, Broggi G.
H3K27me3
Loss in Central Nervous System Tumors: Diagnostic, Prognostic, and
Therapeutic Implications.
Cancers
(Basel). 2024 Oct 11;16(20):3451. doi:
10.3390/cancers16203451. PMID:
39456545. Review. ˍ
Matsuzaki H, Pan C, Komohara Y, Yamada R, Yano H, Fujiwara Y, Kai
K, Mukasa A.
The roles of
glioma-associated macrophages/microglia and potential targets for
anti-glioma therapy.
Immunol
Med. 2024 Oct 11:1-9. doi:
10.1080/25785826.2024.2411035. PMID:
39391957. Review. ˍ
Murphy ES, Sahgal A, Regis J, Levivier M, Fariselli L, Gorgulho A,
Ma L, Pollock B, Yomo S, Sheehan J, Paddick I, Suh JH, Saxena A,
Ahmed MA, Kotecha R.
Pediatric Cranial
Stereotactic Radiosurgery: Meta-Analysis and International
Stereotactic Radiosurgery Society Practice Guidelines.
Neuro
Oncol. 2024 Oct 11:noae204. doi:
10.1093/neuonc/noae204. PMID:
39390948. Meta-analysis; Guidelines˰
ˍ
Toader C, Radoi MP, Dumitru A, Glavan LA, Covache-Busuioc RA, Popa
AA, Costin HP, Corlatescu AD, Ciurea AV.
High-Grade
Thalamic Glioma: Case Report with Literature Review.
Medicina
(Kaunas). 2024 Oct 11;60(10):1667. doi:
10.3390/medicina60101667. PMID:
39459454. Review. ˍ
González-Johnson L, Fariña A, Farías G,
Zomosa G, Pinilla-González V, Rojas-Solé C.
Exploring Neuroprotection against
Radiation-Induced Brain Injury: A Review of Key Compounds.
NeuroSci.
2024 Oct 12;5(4):462-484. doi:
10.3390/neurosci5040034. PMID:
39484304. Review. ˍ
Richard SA, Roy SK, Asiamah EA.
Pivotal
Role of Cranial Irradiation-Induced Peripheral, Intrinsic, and
Brain-Engrafting Macrophages in Malignant Glioma.
Clin
Med Insights Oncol. 2024 Oct 12;18:11795549241282098.
doi:
10.1177/11795549241282098. PMID:
39421649. Review. ˍ
Shaheen S, Aiman U, Haque ZA, Azad Z.
"Navigating
the complexities of low-Grade glioma treatment: insights into SBT
I-125 and novel assessment tools".
Neurosurg
Rev. 2024 Oct 12;47(1):788. doi:
10.1007/s10143-024-03028-1. PMID:
39394531. Perspective˰
ˍ
Yang Z, Zhang X.
The Clinical and
Molecular Landscape of Rosette-Forming Glioneuronal Tumors.
Biomedicines.
2024 Oct 12;12(10):2325. doi:
10.3390/biomedicines12102325. PMID:
39457636. Review. ˍ
Skouras P, Markouli M, Papadatou I, Piperi C.
Targeting
epigenetic mechanisms of resistance to chemotherapy in gliomas.
Crit
Rev Oncol Hematol. 2024 Oct 13;204:104532. doi:
10.1016/j.critrevonc.2024.104532. PMID:
39406277. Review˰ ˍ
Brokāns A, Dolgopolova J, Saulītis A, Spulle U, Rancāns
K, Meiers D, Hasnere S, Balodis A.
Optic
Nerve Glioblastoma with Optic Chiasm Involvement: A Case Report
and a Brief Literature Review.
Medicina (Kaunas).
2024 Oct 14;60(10):1687. doi:
10.3390/medicina60101687. PMID:
39459474. Review. ˍ
de Bont JM, Schouten-van Meeteren AYN.
Long-term
quality of survival after pediatric low-grade glioma.
Childs
Nerv Syst. 2024 Oct 14;40(10):3341-3355. doi:
10.1007/s00381-024-06631-1. PMID:
39400717. Review˰ ˍ
Harrison TJ, Pornsukjantra P, Hagan AJ, Verity SJ.
The
benefit of long-term methylphenidate in childhood brain injury
survivorship: A review.
Appl
Neuropsychol Child. 2024 Oct 14:1-13. doi:
10.1080/21622965.2024.2413091. PMID:
39401258. Review. ˍ
Khagi S, Kotecha R, Gatson NTN, Jeyapalan S, Abdullah HI,
Avgeropoulos NG, Batzianouli ET, Giladi M, Lustgarten L, Goldlust
SA.
Recent advances in Tumor Treating
Fields (TTFields) therapy for glioblastoma.
Oncologist.
2024 Oct 14:oyae227. doi:
10.1093/oncolo/oyae227. PMID:
39401002. Review. ˍ
Morrow K, Sloan A, Olson JJ, Ormond DR.
Congress
of Neurological Surgeons systematic review and evidence-based
guidelines on the management of recurrent diffuse low-grade
glioma: update.
J
Neurooncol. 2024 Oct 14. doi:
10.1007/s11060-024-04838-5. PMID:
39400661. Guidelines˰ ˍ
Wu X, Zhang M, Jiang Q, Li M, Wu Y.
Diagnostic
accuracy of magnetic resonance diffusion tensor imaging in
distinguishing pseudoprogression from glioma recurrence: a
systematic review and meta-analysis.
Expert
Rev Anticancer Ther. 2024 Oct 14;24(11):1177-1185. doi:
10.1080/14737140.2024.2415404. PMID:
39400036. Review; Meta-analysis˰
ˍ
Zhang T, Jiang S, Zhang L, Liu Y, Zheng H, Zhao H, Du S, Xu Y, Lu
X.
A bibliometric analysis of
oncolytic virotherapy combined with immunotherapy.
Hum
Vaccin Immunother. 2024 Oct 14;20(1):2406621. doi:
10.1080/21645515.2024.2406621.
PMID:
39400287. Bibliometric analysis. ˍ
Cohen
KJ,
et al, PDQ Pediatric Treatment Editorial Board.
Childhood
Ependymoma Treatment (PDQ®): Health Professional Version.
PDQ
Cancer Inf Summ.
2024
Oct 15.
NCBI
Bookshelf ID:
NBK65935.
PMID:
26389373.
Review.
ˍ
*Laurin BJ, Treffy R, Connelly JM, Straza M, Mueller WM, Krucoff
MO.
Mesenchymal-type genetic mutations
are likely pre-requisite for glioblastoma multiforme to
metastasize outside the central nervous system: an original case
series and systematic review of the literature.
World
Neurosurg. 2024 Oct 15:S1878-8750(24)01687-5? doi:
10.1016/j.wneu.2024.09.138? PMID:
39419169. Case report; Review˰
ˍ
Liu Y, Zhou F, Ali H, Lathia JD, Chen P.
Immunotherapy
for glioblastoma: current state, challenges, and future
perspectives.
Cell
Mol Immunol. 2024 Oct 15. doi:
10.1038/s41423-024-01226-x. PMID:
39406966.
Review.
ˍ
Quist M, van Os M, van Laake LW, Bovenschen N, Crnko S.
Integration of circadian rhythms and
immunotherapy for enhanced precision in brain cancer treatment.
EBioMedicine.
2024 Oct 15;109:105395. doi:
10.1016/j.ebiom.2024.105395. PMID:
39413708.
Review.
ˍ
Seaton MP, Schmidt JC, Brown NJ, Sahyouni R, Khalessi AA, Ben-Haim
S, Gonda DD.
Contemporary Applications
of Laser Interstitial Thermal Therapy (LITT): A Comprehensive
Systematic Review.
World Neurosurg. 2024 Oct
15:S1878-8750(24)01714-5? doi: 10.1016/j.wneu.2024.10.022? PMID:
39419170. Review˰ ˍ
Liang R, Hu C, Li H, Tang X.
Research
trends of glioma-related epilepsy: A bibliometric analysis from
2004 to 2023.
J
Cent Nerv Syst Dis. 2024 Oct 16;16:11795735241286653.
doi:
10.1177/11795735241286653. PMID:
39420955. Bibliometric analysis. ˍ
Rivera D, Young T, Rao A, Zhang JY, Brown C, Huo L, Williams T,
Rodriguez B, Schupper AJ.
Current
Applications of Raman Spectroscopy in Intraoperative Neurosurgery.
Biomedicines.
2024 Oct 16;12(10):2363. doi:
10.3390/biomedicines12102363. PMID:
39457674. Review. ˍ
Suvarnapathaki S, Serrano-Farias A, Dudley JC, Bettegowda C,
Rincon-Torroella J.
Unlocking the
Potential of Circulating miRNAs as Biomarkers in
Glioblastoma.
Life
(Basel). 2024 Oct 16;14(10):1312. doi:
10.3390/life14101312. PMID:
39459612. Review. ˍ
Dai J, Song S, Chen P, Huang Q, Duan H.
Analyzing
research trends in glioblastoma metabolism: a bibliometric review.
Front
Immunol. 2024 Oct 18;15:1444305. doi:
10.3389/fimmu.2024.1444305. PMID:
39493751. Bibiometric analysis. ˍ
Zhen T, Sun T, Xiong B, Liu H, Wang L, Chen Y, Sun H.
New
insight into targeting the DNA damage response in the treatment of
glioblastoma.
Chin
J Nat Med. 2024 Oct 18;22(10):869-886. doi:
10.1016/S1875-5364(24)60694-1. PMID:
39428180. Review˰ ˍ
Du R, Zhang J, Lukas RV, Tripathi S, Ahrendsen JT, Curran MA,
Dmello C, Zhang P, Stupp R, Rao G, Heimberger AB.
Is
modulation of immune checkpoints on glioblastoma-infiltrating
myeloid cells a viable therapeutic strategy?
Neuro
Oncol. 2024 Oct 19:noae193. doi:
10.1093/neuonc/noae193. PMID:
39427326. Review. ˍ
Hasan S, Mahmud Z, Hossain M, Islam S.
Harnessing
the role of aberrant cell signaling pathways in glioblastoma
multiforme: a prospect towards the targeted therapy.
Mol
Biol Rep. 2024 Oct 19;51(1):1069. doi:
10.1007/s11033-024-09996-3. PMID:
39424705. Review˰ ˍ